Its “Triple G” effect makes its weight loss results more effective than other competitors. In trials, it showed incredible weight loss results, helping patients lose 24% of their body weight in 48 weeks.
Retatrutide vs Tirzepatide vs Semaglutide
Research on retatrutide is still ongoing. However, current clinical trials show that Retatrutide promotes weight loss better than Semaglutide and Tirzepatide. Here are some clinical trial data for reference:
Novo Nordisk’s Semaglutide was found to result in an average weight loss of about 15%, or about 34 pounds, after 68 weeks.
Another weight loss drug from Eli Lilly and Company, Tirzepatide, was shown to reduce body weight by an average of 22.5% after 72 weeks.
After 48 weeks, the experimental drug Retartutide helped people lose an average of 24 percent, the equivalent of 58 pounds. However, the actual effectiveness of Retatrutide may be better because it is limited to time. Phase 3 trials will demonstrate its full potential and long-term impact, making it easier for people to believe in it
Since these drugs have not been directly compared in head-to-head clinical trials, it is safe to say that these comparisons will not be direct comparisons. Retatrutide powder is the active ingredient of retatrutide injection, which can help with weight loss and treat type 2 diabetes. Nonetheless, Retatrutide may be faster and more effective than Tirzepatide and Semaglutide.
- Report Listing Cancel Report
-
- Current rating: 0
- Total votes: 0
- 45 Views